GW Pharmaceuticals Plc, which produces of plant-derived cannabinoid therapeutics, has appointed Scott Giacobello as its chief financial officer, based in the company’s US headquarters in Carlsbad, California. His task will be to help to transition the company from the use of international financial reporting standards to the US generally accepted accounting principles (GAAP) measure. Concurrently, Adam George, CFO since 2012, has become managing director, UK.
GW Pharmaceuticals announced the appointment on 7 March 2017.
Copyright 2017 Evernow Publishing Ltd